EVOKE PHARMA INC's ticker is and the CUSIP is 30049G904. A total of 3 filers reported holding EVOKE PHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $0 | -100.0% | 200 | -98.3% | 0.00% | – |
| Q4 2021 | $6,000 | -97.9% | 11,900 | -94.6% | 0.00% | – |
| Q3 2021 | $289,000 | -4.0% | 219,500 | -0.2% | 0.00% | – |
| Q2 2021 | $301,000 | -28.0% | 219,900 | +9523.6% | 0.00% | -100.0% |
| Q1 2021 | $418,000 | +10.0% | 2,285 | +55.1% | 0.00% | – |
| Q4 2020 | $380,000 | -23.2% | 1,473 | +39.5% | 0.00% | -100.0% |
| Q3 2020 | $495,000 | – | 1,056 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 2,285 | $418,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 115,700 | $212,000 | 0.00% |